Keywords: amgen, buys, renal, specialist, 420m, biotechnology, major

Amgen buys US renal specialist for $420M

Article | 11 June 2007

Biotechnology major Amgen has agreed to acquire Ilypsa, a privately-held fellow USA-based company developing non-absorbed drugs for renal disorders. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing

Related Drugs

Aranesp

Darbepoetin Alfa

Epoetin Alfa

Epogen

Procrit

Go to drug listing